Home › Novavax losses widen on expenses
 

Keywords :   


Novavax losses widen on expenses

2015-02-27 03:31:23| Biotech - Topix.net

Gaithersburg-based Novavax Inc., which began early stage clinical trials for an Ebola vaccine, reports wider quarterly losses on an increase in R&D expenses. Gaithersburg-based Novavax Inc. posted higher full year revenue, but rising research and development costs and a growing workforce increased expenses and widened fourth quarter losses.

Tags: expenses losses widen novavax

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »